922 results on '"Farré, Magí"'
Search Results
52. Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users
53. Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: Initial validation of an imaging protocol for drug discovery
54. Drug‐related deaths in hospital inpatients: A retrospective cohort study
55. Identifying new psychoactive substances (NPS) using drug checking services: An innovative observational study design
56. Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
57. Antipsychotic drugs in cocaine dependence: A systematic review and meta-analysis
58. Use of Antibiotics in Pregnant Patients in the ICU
59. BDNF and cortisol in the diagnosis of cocaine-induced depression
60. Multiple adverse drug reactions and genetic polymorphism testing: A case report with negative result
61. Non-Linear Formation of EtG and FAEEs after Controlled Administration of Low to Moderate Doses of Ethanol
62. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma
63. Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH.
64. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project
65. Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake
66. Altered brain functional connectivity in relation to perception of scrutiny in social anxiety disorder
67. Development and validation of a liquid chromatography–tandem mass spectrometry assay for hair analysis of atomoxetine and its metabolites: Application in clinical practice
68. Changes in CYP1A2 Activity in Humans after 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Administration Using Caffeine as a Probe Drug
69. Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography–tandem mass spectrometry
70. New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
71. Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
72. Clinical Pharmacology of the Synthetic Cathinone Mephedrone
73. Is There a Recreational Misuse Potential for Pregabalin? Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data
74. Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
75. Cocaine Metabolism in Humans after Use of Alcohol Clinical and Research Implications
76. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
77. Abuse Potential of Cathinones in Humans: A Systematic Review
78. Nocebo Response in Attention Deficit Hyperactivity Disorder: Meta-Analysis and Meta-Regression of 105 Randomized Clinical Trials
79. Viral Dynamics in Patients with Monkeypox Infection: A Prospective Cohort Study in Spain
80. 3,4-Methylenedioxymethamphetamine Induces Gene Expression Changes in Rats Related to Serotonergic and Dopaminergic Systems, But Not to Neurotoxicity
81. Anticonvulsant drugs in cocaine dependence: A systematic review and meta-analysis
82. Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World
83. Spontaneous Reporting of Adverse Drug Reactions in a Pediatric Population in a Tertiary Hospital
84. Answer to the Letter to the Editor Concerning “Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism”
85. Alcohol consumption is associated with high concentrations of urinary hydroxytyrosol
86. Complementary phenol-enriched olive oil improves HDL characteristics in hypercholesterolemic subjects. A randomized, double-blind, crossover, controlled trial. The VOHF study
87. Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial1-3
88. Moderate consumption of wine, through both its phenolic compounds and alcohol content, promotes hydroxytyrosol endogenous generation in humans. A randomized controlled trial
89. Liquid chromatography–electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices
90. Absence of drug–drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat
91. Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse
92. Drug-Related Deaths in a Tertiary Hospital: Characteristics of Spontaneously Reported Cases and Comparison to Cases Detected from a Retrospective Study
93. Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study
94. A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
95. En el filo de la duda: investigación epidemiológica y aspectos bioéticos y psicológicos en la pandemia de VIH
96. Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial
97. Biodistribution and Radiation Dosimetry of the Glycine Transporter-1 Ligand 11C-GSK931145 Determined from Primate and Human Whole-Body PET
98. Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans
99. Liquid chromatography–atmospheric pressure ionization electrospray mass spectrometry determination of “hallucinogenic designer drugs” in urine of consumers
100. Placebo response in the prophylaxis of migraine: A meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.